Affirming support for most-favored-Nation drug pricing for United States patients.

This resolution states the House of Representatives' position on prescription drug prices. It says patients in the United States should not be charged more than patients in other countries for the same prescription drugs. It supports policies that would match U.S. drug prices to those in other developed nations, along with expanding Medicare drug price negotiation and promoting price competition. The resolution expresses a position and does not create new laws or spending.

Full text and official record on Congress.gov

Sponsors

• Debbie Dingell Democrat sponsor
• 1 cosponsors